Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’

Sabrina J. Merat; Camille Bru; Dorien van de Berg; Richard Molenkamp; Alexander W. Tarr; Sylvie Koekkoek; Neeltje A. Kootstra; Maria Prins; Jonathan Ball; Arjen Q. Bakker; Menno D. de Jong; Hergen Spits; Tim Beaumont; Janke Schinkel

doi:10.1016/j.jhep.2020.07.004

Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’

Sabrina J. Merat
, Camille Bru
, Dorien van de Berg
, Richard Molenkamp
, Alexander W. Tarr
, Sylvie Koekkoek
, Neeltje A. Kootstra
, Maria Prins
, Jonathan Ball
, Arjen Q. Bakker
, Menno D. de Jong
, Hergen Spits
, Tim Beaumont
, Janke Schinkel

Research output: Other contribution

Abstract

It has come to our attention that there is an error in Fig. 2A and consequently the Graphical Abstract of our manuscript. During the production process, the colors used in the legend to the pie chart were incorrectly assigned, so that those representing AR3 and AR4 were reversed. Please see the corrected Fig. 2 and Graphical Abstract below. We apologize for any inconvenience caused.

Original language	English
Number of pages	2
Edition	4
Volume	73
DOIs	https://doi.org/10.1016/j.jhep.2020.07.004
Publication status	Published - 1 Oct 2020
Externally published	Yes

Publication series

Name	Journal of Hepatology
Publisher	Elsevier B.V.
ISSN (Print)	0168-8278

Access to Document

10.1016/j.jhep.2020.07.004

Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance
Merat, S. J., Bru, C., van de Berg, D., Molenkamp, R., Tarr, A. W., Koekkoek, S., Kootstra, N. A., Prins, M., Ball, J., Bakker, A. Q., de Jong, M. D., Spits, H., Beaumont, T. & Schinkel, J., 1 Jul 2019, In: Journal of Hepatology. 71, 1, p. 14-24 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
29 Citations (Scopus)

Cite this

Merat, S. J., Bru, C., van de Berg, D., Molenkamp, R., Tarr, A. W., Koekkoek, S., Kootstra, N. A., Prins, M., Ball, J., Bakker, A. Q., de Jong, M. D., Spits, H., Beaumont, T., & Schinkel, J. (2020, Oct 1). Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’. (4 ed.) https://doi.org/10.1016/j.jhep.2020.07.004

@misc{7e26273a4e5c4ebbb48247f91bc31f40,

title = "Erratum to: {\textquoteleft}Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance{\textquoteright}",

abstract = "It has come to our attention that there is an error in Fig. 2A and consequently the Graphical Abstract of our manuscript. During the production process, the colors used in the legend to the pie chart were incorrectly assigned, so that those representing AR3 and AR4 were reversed. Please see the corrected Fig. 2 and Graphical Abstract below. We apologize for any inconvenience caused.",

author = "Merat, \{Sabrina J.\} and Camille Bru and \{van de Berg\}, Dorien and Richard Molenkamp and Tarr, \{Alexander W.\} and Sylvie Koekkoek and Kootstra, \{Neeltje A.\} and Maria Prins and Jonathan Ball and Bakker, \{Arjen Q.\} and \{de Jong\}, \{Menno D.\} and Hergen Spits and Tim Beaumont and Janke Schinkel",

year = "2020",

month = oct,

day = "1",

doi = "10.1016/j.jhep.2020.07.004",

language = "English",

volume = "73",

series = "Journal of Hepatology",

publisher = "Elsevier B.V.",

edition = "4",

type = "Other",

}

TY - GEN

T1 - Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’

AU - Merat, Sabrina J.

AU - Bru, Camille

AU - van de Berg, Dorien

AU - Molenkamp, Richard

AU - Tarr, Alexander W.

AU - Koekkoek, Sylvie

AU - Kootstra, Neeltje A.

AU - Prins, Maria

AU - Ball, Jonathan

AU - Bakker, Arjen Q.

AU - de Jong, Menno D.

AU - Spits, Hergen

AU - Beaumont, Tim

AU - Schinkel, Janke

PY - 2020/10/1

Y1 - 2020/10/1

N2 - It has come to our attention that there is an error in Fig. 2A and consequently the Graphical Abstract of our manuscript. During the production process, the colors used in the legend to the pie chart were incorrectly assigned, so that those representing AR3 and AR4 were reversed. Please see the corrected Fig. 2 and Graphical Abstract below. We apologize for any inconvenience caused.

AB - It has come to our attention that there is an error in Fig. 2A and consequently the Graphical Abstract of our manuscript. During the production process, the colors used in the legend to the pie chart were incorrectly assigned, so that those representing AR3 and AR4 were reversed. Please see the corrected Fig. 2 and Graphical Abstract below. We apologize for any inconvenience caused.

U2 - 10.1016/j.jhep.2020.07.004

DO - 10.1016/j.jhep.2020.07.004

M3 - Other contribution

VL - 73

T3 - Journal of Hepatology

ER -

Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’

Abstract

Publication series

Access to Document

Fingerprint

Research output

Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance

Cite this